Allergy and Immunology · Wexford, PA
NPI
1174559561
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6400 Brooktree Ct., Suite 230
Wexford, PA, 15090
Phone (724) 719-2441
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,994
400 services
Medicare patients, 2024
96
Average age 72
Drug cost, 2024
$620K
980 prescriptions
Company payments, 2025
$882
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shernaaz B Kapadia was code 99213 (office e&m - established), 54 times for 49 patients. In total Shernaaz B Kapadia billed 400 services in 12 codes, and Medicare paid $8,994.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 54 | 49 | $58.02 | $3,133 |
| 99203 Office E&M - New | Office | 27 | 27 | $77.78 | $2,100 |
| 99214 Office E&M - Established | Office | 23 | 22 | $77.62 | $1,785 |
By year: 2022 $14K for 834 services; 2023 $12K for 656 services; 2024 $8,994 for 400 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shernaaz B Kapadia prescribed most often to Medicare patients was Montelukast Sodium, with 307 prescriptions and refills. In total Shernaaz B Kapadia wrote 980 Medicare prescriptions that cost $620K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 307 | 653 | 77 | $3,216 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 60 | 74 | 15 | $15K |
| Levocetirizine Dihydrochloride Generic | 53 | 101 | 11 | $698 |
| Azelastine Hcl Generic | 53 | 82 | 21 | $1,655 |
| Breo Ellipta Fluticasone/Vilanterol | 43 | 93 | 12 | $34K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 40 | 58 | 31 | $1,794 |
| Epinephrine Generic | 35 | 38 | 32 | $6,429 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 33 | 67 | Under 11 | $9,168 |
| Xolair Omalizumab | 27 | 27 | Under 11 | $73K |
| Fluticasone Propionate Generic | 27 | 53 | 11 | $359 |
| Arnuity Ellipta Fluticasone Furoate | 26 | 48 | Under 11 | $11K |
| Advair Hfa Fluticasone Propion/Salmeterol | 22 | 26 | Under 11 | $8,727 |
| Ipratropium Bromide Generic | 17 | 30 | Under 11 | $908 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 16 | 20 | Under 11 | $4,268 |
| Mometasone Furoate Generic | 15 | 16 | Under 11 | $367 |
Brand drugs: 343 claims; generic drugs: 637 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shernaaz B Kapadia $882 ($882 in general payments such as food, travel and fees) from 12 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 22 | $279 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $185 |
| CSL Behring CSL.AX | 5 | $91.19 |
| GlaxoSmithKline, LLC. GSK | 4 | $82.95 |
| Genzyme Corporation SNY | 3 | $58.69 |
| BioCryst US Sales Co., LLC | 1 | $37.86 |
| Pharming Healthcare, Inc. | 2 | $37.01 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $25.72 |
| Invivyd Inc IVVD | 1 | $22.83 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $22.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.